Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › ME › Portland › NPI 1366474611
Physician

Martin's Point Health Care, INC.

Martin's Point Health Care, INC. was paid $5.94M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 78% of everything it billed.

33Billing provider infoMARTIN'S POINT HEALTH CARE, INC.
PORTLAND, ME 04104
33aNPI1366474611assigned 07/07/2006
28Total paid$5.94M
24GClaims126,008
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Neuromusculoskeletal Medicine & OMM Physician providers in Maine

Rank by total paid#1 of 14
Median peer was paid$61K
This provider vs. median98×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201815,495$685K
201916,183$709K
202013,283$549K
202125,123$939K
202219,786$1.03M
202319,942$1.12M
2024incomplete16,196$908K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 78% 67,466 62,580 $4.60M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 15% 17,570 16,341 $888K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1.3% 4,608 4,470 $75K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.1% 1,958 1,688 $63K
0011A <1% 1,535 1,521 $34K
0012A <1% 1,513 1,499 $33K
36415 Collection of venous blood by venipuncture <1% 14,934 13,658 $21K
90686 <1% 2,502 2,415 $20K
80053 Comprehensive metabolic panel <1% 2,947 2,770 $19K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 627 612 $17K
77067 Screening mammography, bilateral, including computer-aided detection <1% 408 404 $16K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 188 181 $16K
55 more codes
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 224 $15K
99215 Doctor's office visit, returning patient (complex) <1% 122 $13K
90472 Immunization administration, each additional vaccine (list separately) <1% 938 $13K
99203 Doctor's office visit, new patient (routine) <1% 157 $10K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 1,690 $8K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 84 $6K
80305 <1% 887 $6K
99204 Doctor's office visit, new patient (more involved) <1% 69 $6K
80061 Lipid panel <1% 540 $5K
84443 Thyroid stimulating hormone (TSH) <1% 403 $4K
99442 <1% 198 $4K
77063 Screening digital breast tomosynthesis, bilateral <1% 407 $4K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 50 $4K
90682 <1% 37 $3K
0001A <1% 88 $3K
0240U <1% 32 $3K
0002A <1% 72 $3K
0064A <1% 78 $2K
98927 <1% 67 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 78 $2K
99334 <1% 51 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 15 $1K
92551 <1% 120 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 55 $1K
96127 <1% 208 $1K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 38 $958.32
90673 <1% 13 $907.50
83036 Hemoglobin; glycosylated (A1C) <1% 129 $849.43
71046 Radiologic examination, chest; 2 views <1% 66 $737.14
0031A <1% 44 $723.64
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 14 $664.44
93000 <1% 90 $612.63
90480 <1% 14 $547.54
99177 <1% 55 $537.68
92552 <1% 28 $360.92
90461 <1% 13 $325.92
99441 <1% 39 $309.03
D1206 Topical application of fluoride varnish <1% 12 $294.72
99173 <1% 59 $249.57
83655 <1% 13 $148.44
94760 <1% 73 $148.40
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 12 $128.81
96160 <1% 40 $76.81
80048 Basic metabolic panel (calcium, ionized) <1% 15 $50.25
85018 <1% 15 $31.46
91301 0% 1,888 $0.00
G0008 Administration of influenza virus vaccine 0% 30 $0.00
91307 0% 43 $0.00
90656 0% 87 $0.00
91306 0% 43 $0.00
90698 0% 12 $0.00
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 0% 13 $0.00
91308 0% 12 $0.00
90671 0% 14 $0.00
91300 0% 158 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCCORMACK, DAN (CHIEF OPERATING OFFICER)